The diagnosis and treatment of neonatal herpes simplex virus infection

Pediatric Annals

Volumn 31, Issue 11, 2002, Pages 726-732

  Kohl, Steve ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FOSCARNET SODIUM; IDOXURIDINE; TRIFLURIDINE; VIDARABINE;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HUMAN; NEPHROTOXICITY; NEUTROPENIA; NEWBORN; NEWBORN INFECTION; REVIEW; VIRUS DIAGNOSIS;

EID: 0036845063     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20021101-09     Document Type: Review

References (16)

1. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997;337:1105-1111.
2. Sullivan-Bolyai JZ, Hull HF, Wilson C, et al. Neonatal herpes simplex virus infection in King county, Washington: Increasing incidence and epidemiologic correlates. JAMA. 1983;250:3059-3062.
3. Guitierrez KM, Falkovitz Halpern MS, Maldonado Y, Arvin AM. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis. 1999;180:199-202.
4. Brown Z, Selke S, Zeh J, et al. Transmission Rates of HSV from Mother to Infant. Paper presented at the Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sept. 1999; 423.
5. Kulhanjian JA, Soroush V, Au DS, et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med. 1992;326:916-920.
6. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509-515.
7. Malm G, Berg U, Forsgren M. Neonatal herpes simplex: Clinical findings and outcome in relation to type of maternal infection. Acta Paediatr. 1995;84:256-260.
8. Kimberlin DW, Lin CY, Jacobs FJ, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108:223-229.
9. Whitley RJ, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med. 1991;324:450-454.
10. Kohl S. Neonatal herpes simplex virus infection. Infections in Perinatology. 1997;24:129-150.
11. Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction (PCR) to the diagnosis and management of herpes simplex virus disease. J Infect Dis. 1996;174:1162-1167.
12. Whitley RJ, Nahmias AJ, Soong SJ, et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics. 1980;66:495-501.
13. Whitley RJ, Arvin AM, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med. 1991;324:444-449.
14. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108:230-238.
15. Kimberlin D, Powell D, Bruger W, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial. Pediatr Infect Dis J. 1996;15:247-254.
16. Scott LL, Sanchez PJ, Jackson GL, et al. Acyclovir suppression to prevent Caesarian section after first episode genital herpes. Obstetr Gynecol. 1996;87:69-73.